USPTO serial 99976171
TRUVETA GENOME PROJECT
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with TRUVETA GENOME PROJECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $896*
Plus Government fees of $500
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bellevue, WA, US
Bellevue, WA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Breakstone
Elizabeth Breakstone Hillis Clark Martin & Peterson P.S.999 Third Avenue, Suite 4600Seattle, WA 98104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Collecting and analyzing claims data from healthcare organizations for business purposes; Collection and analysis of quality metric data for a network of health care providers for business purposes; Analyzing and compiling business data in the fields of nucleic acid sequencing, genotyping, medical research, medical diagnostics, clinical research, clinical diagnostics, drug development research, and genetic testing | ACTIVE | — |
| 038 | Providing access to an electronic exchange of medical records across a nationwide health information network; Electronic exchange of medical records across a nationwide health information network | ACTIVE | — |
| 042 | Providing online non-downloadable computer software for the custom design and ordering of assays, agents, enzymes, nucleotides, nucleic acids, buffers, chemical preparations, biological preparations, and reagents in the fields of medical research, medical diagnostics, clinical research, clinical diagnostics, drug development research, and genetic testing; Providing online non-downloadable computer software that enables users to store, analyze, integrate, exchange, and share data in the fields of nucleic acid sequencing, medical research, clinical research, drug development research, and genetic testing; Providing information in the fields of nucleic acid sequencing for medical research, clinical diagnostics research, medical research, clinical research, and drug development to others via an online searchable database; Providing scientific and research information in the fields of life sciences, biology, microbiology, biotechnology, genetics, and oncology to others via an online searchable database; Providing online non-downloadable computer software for providing a searchable database of de-identified electronic health records and de-identified patient genetic information for medical diagnostic and treatment purposes; Providing a website featuring medical and scientific research information on advances in the fields of human health and diagnostic treatment strategies of human diseases, human genetic research and development, and pharmaceutical research and development; Genome sequencing and analysis services for scientific and research purposes; Providing computer programming services that enable queries of a healthcare database for the purpose of retrieving health information; Providing online non-downloadable computer software for collecting, storing, and analyzing de-identified electronic health records and de-identified patient genetic information | ACTIVE | — |
| 044 | Nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; Providing an online searchable database in the field of healthcare featuring information from multiple entities relating to healthcare issues; Medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses; Providing information in the fields of nucleic acid sequencing for medical diagnostic and treatment purposes, medicine, medical diagnostics, clinical medical diagnostics, genetic testing for medical purposes, oncology for medical purposes, and healthcare to others via an online searchable database | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Truveta Inc.
- Other trademarks owned by Truveta Inc.
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRUVETA GENOME PROJECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 17, 2026 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jul 17, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 17, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 17, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 1, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 20, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 28, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 28, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 12, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 20, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 20, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2025 | NWAP | NEW APPLICATION ENTERED | — |